Regulation of RHOV signaling by interaction with SH3 domain-containing adaptor proteins and phosphorylation by PKA.

PKA Phosphorylation Protein-protein interaction RHOV SH3 domain

Journal

Biochemical and biophysical research communications
ISSN: 1090-2104
Titre abrégé: Biochem Biophys Res Commun
Pays: United States
ID NLM: 0372516

Informations de publication

Date de publication:
28 Jun 2024
Historique:
received: 08 06 2024
revised: 11 06 2024
accepted: 27 06 2024
medline: 3 7 2024
pubmed: 3 7 2024
entrez: 3 7 2024
Statut: aheadofprint

Résumé

RHOV and RHOU are considered atypical Rho-family small GTPases because of the existence of N- and C-terminal extension regions, abnormal GDP/GTP cycling, and post-translational modification. Particularly, RHOV and RHOU both have a proline-rich (PR) motif in the N-terminal region. It has been reported that the PR motif of RHOU interacts with GRB2, a SH3 domain-containing adaptor protein, and regulates its activity through EGF receptor signaling. However, it is unknown whether RHOV, like RHOU, interacts with SH3 domain-containing adaptor proteins. In this study, we investigated the interactions between RHOV and SH3 domain-containing adaptor proteins, including GRB2 and NCK2. The RHOV-induced serum response factor (SRF)-dependent gene transcriptional activity was attenuated in cells co-expressing either GRB2 or NCK2 compared to cells expressing RHOV alone. From the results of experiments using various gene mutants of RHOV and GRB2, it appears that the PR motif of the N-terminal region of RHOV is the crucial binding site for the SH3 domain-containing proteins. Furthermore, we found that Ser25 in the N-terminal region of RHOV is phosphorylated by PKA and that its phosphorylation is suppressed by interaction with NCK2 but not GRB2. We have found a novel regulatory mechanism for the phosphorylation of RHOV and its interaction with SH3 domain-containing adaptor proteins.

Identifiants

pubmed: 38959529
pii: S0006-291X(24)00861-1
doi: 10.1016/j.bbrc.2024.150325
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

150325

Informations de copyright

Copyright © 2024 Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Eka Wahyuni Harlin (EW)

United Graduate School of Drug Discovery and Medical Information Sciences, Gifu University, Yanagido1-1, Gifu, 501-1193, Japan.

Takuya Ito (T)

Department of Chemistry and Biomolecular Science, Faculty of Engineering, Gifu University, Yanagido 1-1, Gifu, 501-1193, Japan.

Shun Nakano (S)

United Graduate School of Drug Discovery and Medical Information Sciences, Gifu University, Yanagido1-1, Gifu, 501-1193, Japan.

Kohei Morikawa (K)

United Graduate School of Drug Discovery and Medical Information Sciences, Gifu University, Yanagido1-1, Gifu, 501-1193, Japan.

Katsuya Sato (K)

Department of Molecular Pathobiochemistry, Gifu University Graduate School of Medicine, Yanagido 1-1, Gifu, 501-1193, Japan.

Masashi Nishikawa (M)

United Graduate School of Drug Discovery and Medical Information Sciences, Gifu University, Yanagido1-1, Gifu, 501-1193, Japan.

Katsuyuki Nakamura (K)

Department of Chemistry and Biomolecular Science, Faculty of Engineering, Gifu University, Yanagido 1-1, Gifu, 501-1193, Japan.

Hitoshi Nagaoka (H)

Department of Molecular Pathobiochemistry, Gifu University Graduate School of Medicine, Yanagido 1-1, Gifu, 501-1193, Japan; Center for One Medicine Innovative Translational Research (COMIT), Gifu University, 1-1 Yanagido, Gifu, Gifu, 501-1193, Japan.

Takahiro Nagase (T)

Kazusa DNA Research Institute, Chiba, Japan.

Hiroshi Ueda (H)

United Graduate School of Drug Discovery and Medical Information Sciences, Gifu University, Yanagido1-1, Gifu, 501-1193, Japan; Department of Chemistry and Biomolecular Science, Faculty of Engineering, Gifu University, Yanagido 1-1, Gifu, 501-1193, Japan; Center for One Medicine Innovative Translational Research (COMIT), Gifu University, 1-1 Yanagido, Gifu, Gifu, 501-1193, Japan. Electronic address: ueda.hiroshi.j6@f.gifu-u.ac.jp.

Classifications MeSH